Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Vandenbroucke-Grauls, C.M.J.E.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

LETTER

Vancomycin-Resistant Staphylococcus aureus

right arrow C.M.J.E. Vandenbroucke-Grauls, MD, PhD

15 November 1996 | Volume 125 Issue 10 | Page 859


TO THE EDITOR:

In their paper on measures for control of vancomycin-resistant S. aureus, Edmond and colleagues [1] thoroughly review the measures that should be followed to prevent nosocomial transmission of these strains. However, they state that their proposals are based on the limited data available on the control and transmission of S. aureus. In the Netherlands, we have experience with control of methicillin-resistant S. aureus. Since 1988, ongoing surveillance by the National Institute of Public Health and Environmental Protection shows that in the Netherlands (a country that has 15 million inhabitants and about 150 hospitals), the number of cases of methicillin-resistant S. aureus remains constant at approximately 200 per year [2, 3]. Because there is no reason to assume that the epidemiology of methicillin-resistant S. aureus differs from that of vancomycin-resistant strains, we believe that our success provides a good basis for the control of vancomycin-resistant S. aureus.

National guidelines have been issued by a Working Party on Infection Control and endorsed by the National Health Council [4]. The general principles of the guidelines for control of methicillin-resistant S. aureus concur with those proposed by Edmond and colleagues [1]. The main differences are the following: 1) Because S. aureus often manifests in the anterior nares and because of the possibility of shedding, we require that a mask be worn by anyone entering the isolation room; 2) we do not do environmental cultures; 3) we avoid unnecessary diagnostic procedures that require the patient to leave the isolation room but do not avoid these procedures when they are required [we believe that patients colonized with methicillin-resistant S. aureus have the same right to good medical care as do other patients], and precautions are taken for patients leaving the room; and 4) we do not advise special precautions for handling patient specimens or take any additional measures in the microbiology laboratory (we have had no evidence of transmission of methicillin-resistant S. aureus in the laboratory).

We agree with Edmond and colleagues that prevention is better than cure and that infection-control guidelines should be instated before a problem arises. We hope that the Dutch experience might help.


Author and Article Information
space
up arrowTop
dotAuthor & Article Info
down arrowReferences

University Hospital Vrije Universiteit, Amsterdam, the Netherlands.


References
space
up arrowTop
up arrowAuthor & Article Info
dotReferences

1. Edmond MB, Wenzel RP, Pasculle AW. Vancomycin-resistant Staphylococcus aureus: perspectives on measures needed for control. Ann Intern Med. 1996; 124:329-34.

2. van Leeuwen WJ, Schot CS, Rost JA, Neeling AJ, van Klingeren B. Surveillance of Methicillin-Resistant Staphylococcus aureus in the Netherlands from 1992 to 1994. National Institute of Public Health and Environmental Protection Report no. 359002004; 1995.

3. Vandenbroucke-Grauls CM. Epidemiology of staphylococcal infections: a European perspective. J Chemother. 1994; 6(Suppl 2):35-9.

4. Management Policy for Methicillin-Resistant Staphylococcus aureus. Guideline of the Working Party Infection Prevention. No. 35a; 1995.

About Letters
space

The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

•Include no more than 300 words of text, three authors, and five references

•Type with double-spacing

•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

Annals welcomes electronically submitted letters.





box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Vandenbroucke-Grauls, C.M.J.E.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space


 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online